ICD implantation

DEVICE10 trials

Conditions

At Least 10 Points in Rassi Risk Score for DeathCardiomyopathy IschemicChagas CardiomyopathyCoronary Artery DiseaseHeart FailureHeart Failure With Reduced Ejection FractionICDImplantable Cardioverter Defibrillator

Unknown Phase

Substrate Modification in Stable Ventricular Tachycardia in Addition to Implantable Cardioverter Defibrillator (ICD) Therapy

CompletedNCT00919373

Abbott Medical DevicesCoronary Artery Disease, Left Ventricular Dysfunction, Ventricular Tachycardia

Start: 2002-07-31End: 2006-01-31Updated: 2019-02-04

AnalyST Treadmill Study

CompletedNCT00949000

Abbott Medical DevicesIschemic Heart Disease

Start: 2009-07-31End: 2011-02-28Target: 50Updated: 2019-02-04

Amiodarone Against ICD Therapy in Chagas Cardiomyopathy for Primary Prevention of Death

NCT01722942

InCor Heart InstituteAt Least 10 Points in Rassi Risk Score for Death, Chagas Cardiomyopathy, Non-sustained Ventricular Tachycardia

Start: 2014-10-06End: 2022-07-31Target: 1100Updated: 2021-08-30

Risk Stratification in Patients With Preserved Ejection Fraction

CompletedNCT02124018

University of AthensMyocardial Infarction

Start: 2014-04-01End: 2018-07-31Updated: 2019-09-04

Benefits of ICD for the Primary Prevention in Patients With Valvular Cardiomyopathy

TerminatedNCT03590730

Keimyung University Dongsan Medical CenterImplantable Cardioverter Defibrillator, Primary Prevention, Sudden Cardiac Death +1

Start: 2017-11-15End: 2021-07-15Updated: 2023-10-19

Assessment of Risk Factors for Appropriate ICD (Implantable Cardioverter-defibrillator) Intervention in Patients With Ischemic Cardiomyopathy

CompletedNCT04014946

Biotronik SE & Co. KGCardiomyopathy Ischemic, ICD, Primary Prevention

Start: 2012-07-24End: 2020-07-22Updated: 2020-09-29

Cardioverter DefIbriIlator PlacEMent for priMary Prevention of Sudden cArdiac Death in Patients Older Than 70 Years

RecruitingNCT05373940

Assistance Publique - Hôpitaux de ParisHeart Failure, Implantable Cardioverter Defibrillator, Primary Prevention of Sudden Cardiac Death

Start: 2022-06-29End: 2030-05-31Target: 730Updated: 2026-03-24

Improving the Criteria for Selecting Patients for Primary Prevention of Sudden Cardiac Death by Arrhythmic Risk Stratification

NCT05539898

Astrakhan Federal Centre For Cardiac SurgeryHeart Failure With Reduced Ejection Fraction

Start: 2017-01-13End: 2024-12-29Target: 450Updated: 2023-02-01

Comparative Effectiveness of Prophylactic ICD Versus Non-ICD Therapy

TerminatedNCT06543446

University of RochesterHeart Failure With Reduced Ejection Fraction

Start: 2025-03-04End: 2026-04-30Updated: 2026-05-12

Dilated Cardiomyopathy - Unknown Therapeutic Risk Reduction by Contempary Medication and Implantable Cardioverter-Defibrillators (DUTCH-ICD)

Not yet recruitingNCT07415642

University Medical Center GroningenSudden Cardiac Death

Start: 2026-03-01End: 2032-12-31Target: 720Updated: 2026-02-17

Frontiers in Cardiovascular Medicine2026-07-03

Rationale and design of the comparative effectiveness of ICD vs non-ICD therapy in contemporary heart failure patients at a low risk for arrhythmic death (CONTEMP-ICD) trial.

2025-09-04

Amiodarone or Implantable Cardioverter-Defibrillator in Chagas Cardiomyopathy

JAMA Cardiology2024-10-0220 citations

Arrhythmic risk stratification in post-myocardial infarction patients with preserved ejection fraction: the PRESERVE EF study

European Heart Journal2019-04-11133 citations

CHronic use of Amiodarone aGAinSt Implantable cardioverter-defibrillator therapy for primary prevention of death in patients with Chagas cardiomyopathy Study: rationale and design of a randomized clinical trial.

2013-10-1128 citations

Catheter ablation of stable ventricular tachycardia before defibrillator implantation in patients with coronary heart disease (VTACH): a multicentre randomised controlled trial.

2010-01-01559 citations

ICD implantation

Sponsors

Conditions

Unknown Phase

Related Papers